scholarly journals Identification of Indicators for Preterm Birth Using Retinoid Metabolites

Metabolites ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 443
Author(s):  
Young-Ah You ◽  
Soo-Yeon Hwang ◽  
Soo-Min Kim ◽  
Seojeong Park ◽  
Ga-In Lee ◽  
...  

Metabolites reflect the biochemical dynamics for the maintenance of pregnancy and parturition. UPLC-Q/TOF-MS and LC-MS/MS metabolomics were performed to identify and validate the plasma metabolomic signatures of preterm birth (PTB). We recruited pregnant women between 16 and 40 weeks 5 days gestational age at Ewha Womans Mokdong Hospital for a nested case-control study. In untargeted UPLC-Q/TOF-MS, score plots of partial least-squares discriminant analysis clearly separated the PTB group from the term birth (TB, n = 10; PTB, n = 11). Fifteen metabolites were significantly different between the two groups, as indicated by a variable importance in projection >1 and p < 0.05. Metabolic pathways involving retinol, linoleic acid, D-arginine, and D-ornithine were associated with PTB. Verification by LC-MS/MS focused on retinol metabolism (TB, n = 39; PTB, n = 20). Retinol levels were significantly reduced in PTB compared to TB, while retinal palmitate, all-trans-retinal, and 13-cis-retinoic acid (13cis-RA) significantly increased (p < 0.05). Retinol-binding protein levels were also elevated in PTB. Additionally, all-trans-retinal (AUC 0.808, 95% CI: 0.683–0.933) and 13cis-RA (AUC 0.826, 95% CI: 0.723–0.930) showed improved predictions for PTB-related retinol metabolites. This study suggests that retinoid metabolism improves the accuracy of PTB predictions and plays an important role in maintaining pregnancy and inducing early parturition.

2012 ◽  
Vol 72 (5) ◽  
pp. 1190-1198 ◽  
Author(s):  
Stephanie J. Weinstein ◽  
Rachael Z. Stolzenberg-Solomon ◽  
William Kopp ◽  
Helen Rager ◽  
Jarmo Virtamo ◽  
...  

2011 ◽  
Vol 9 (1) ◽  
pp. 71-78 ◽  
Author(s):  
L. M. HILTUNEN ◽  
H. LAIVUORI ◽  
A. RAUTANEN ◽  
R. KAAJA ◽  
J. KERE ◽  
...  

2021 ◽  
Vol 2021 (1) ◽  
Author(s):  
Michael S. Bloom ◽  
Kelly Garcia ◽  
Roy R. Gerona ◽  
Edward L. Valachovic ◽  
Victor Y. Fujimoto ◽  
...  

2019 ◽  
Author(s):  
Xing Chen ◽  
Ning Huang ◽  
Chaoqun Liu ◽  
Yue Chen ◽  
Lulu Huang ◽  
...  

Abstract Background: Gut microbiota has been proven to disease susceptibility and may lead to increased risk of preterm birth. To date, the link of gut microbial-related metabolite trimethylamine-N-oxide (TMAO), L-carnitine, and betaine, with spontaneous preterm birth (sPTB) has not been established. This study aimed to investigate the association of TMAO, L-carnitine and betaine, with sPTB risk. Methods: A nested case-control study was designed including 129 sPTB cases and 258 controls based on Guangxi Birth Cohort Study. TMAO, L-carnitine, and betaine level in maternal serum were determined by liquid chromatography with mass spectrometry. Conditional logistic regression analyses were used to examine the association between maternal serum metabolites and sPTB. Stratified analyses were further conducted according to BMI and preterm prelabor rupture of membranes. Spline analyses were performed to explore the dose-response relationship between the metabolites and sPTB.Results: Statistically significant association with decreased sPTB risk was observed for the highest L-carnitine (OR: 0.47; 95% CI: 0.23, 0.95). In risk analyses stratified by BMI, similar results were observed in normal weight gravida (BMI: 18.5~23.9 kg/cm2). The significant subtype-specific association with TMAO (OR: 0.43; 95% CI: 0.20, 0.93) and L-carnitine (OR: 0.45; 95% CI: 0.21, 0.97) were observed for preterm labor but not PPROM. Spline regression analysis indicated non-linear associations with TMAO and sPTB risk (P for nonlinearity: 0.057). Significant associations of TMAO with sPTB were observed in normal weight gravida (P = 0.028) and preterm labor subtype (P = 0.025). No statistically significant associations with sPTB risk were observed for betaine (P > 0.05).Conclusions: TMAO and L-carnitine levels in maternal serum are inversely linked with sPTB risk. Discovery of the association between gut-microbiota initiated TMAO metabolism and sPTB may open new avenues for diagnose and therapy.


2016 ◽  
Vol 124 (9) ◽  
pp. 1479-1486 ◽  
Author(s):  
Olivier Laurent ◽  
Jianlin Hu ◽  
Lianfa Li ◽  
Michael J. Kleeman ◽  
Scott M. Bartell ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document